Roche, Aspreva Evaluating Filing Options For CellCept In Lupus Following Phase III Failure
This article was originally published in The Pink Sheet Daily
Executive Summary
Preliminary data from the induction phase of the trial show the study did not meet its primary superiority endpoint.